These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24325232)

  • 1. Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives.
    Dalamaga M
    Biomark Med; 2014; 8(1):107-18. PubMed ID: 24325232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans.
    Huang X; Yang Z
    J Endocrinol Invest; 2016 Jun; 39(6):607-15. PubMed ID: 26662574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of resistin as a regulator of inflammation: Implications for various human pathologies.
    Filková M; Haluzík M; Gay S; Senolt L
    Clin Immunol; 2009 Nov; 133(2):157-70. PubMed ID: 19740705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistin: insulin resistance to malignancy.
    Codoñer-Franch P; Alonso-Iglesias E
    Clin Chim Acta; 2015 Jan; 438():46-54. PubMed ID: 25128719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocytokine resistin and breast cancer risk.
    Sun CA; Wu MH; Chu CH; Chou YC; Hsu GC; Yang T; Chou WY; Yu CP; Yu JC
    Breast Cancer Res Treat; 2010 Oct; 123(3):869-76. PubMed ID: 20177966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters.
    Dalamaga M; Sotiropoulos G; Karmaniolas K; Pelekanos N; Papadavid E; Lekka A
    Clin Biochem; 2013 May; 46(7-8):584-90. PubMed ID: 23321342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of resistin in obesity-induced insulin resistance.
    Haluzik M; Haluzikova D
    Curr Opin Investig Drugs; 2006 Apr; 7(4):306-11. PubMed ID: 16625816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of resistin in inflammation and inflammation-related diseases.
    Pang SS; Le YY
    Cell Mol Immunol; 2006 Feb; 3(1):29-34. PubMed ID: 16549046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
    Dalamaga M
    Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperresistinemia is associated with postmenopausal breast cancer.
    Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
    Menopause; 2013 Aug; 20(8):845-51. PubMed ID: 23481121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistin- and Obesity-associated metabolic diseases.
    Lazar MA
    Horm Metab Res; 2007 Oct; 39(10):710-6. PubMed ID: 17952831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella NA
    Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The obesity-cancer link: lessons learned from a fatless mouse.
    Hursting SD; Nunez NP; Varticovski L; Vinson C
    Cancer Res; 2007 Mar; 67(6):2391-3. PubMed ID: 17363554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lycopene supplementation modulates plasma concentrations and epididymal adipose tissue mRNA of leptin, resistin and IL-6 in diet-induced obese rats.
    Luvizotto Rde A; Nascimento AF; Imaizumi E; Pierine DT; Conde SJ; Correa CR; Yeum KJ; Ferreira AL
    Br J Nutr; 2013 Nov; 110(10):1803-9. PubMed ID: 23632237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistin in metabolism, inflammation, and disease.
    Tripathi D; Kant S; Pandey S; Ehtesham NZ
    FEBS J; 2020 Aug; 287(15):3141-3149. PubMed ID: 32255270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects associated with adipose tissue distribution.
    Zahorska-Markiewicz B
    Adv Med Sci; 2006; 51():111-4. PubMed ID: 17357288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and cancer risk: Emerging biological mechanisms and perspectives.
    Avgerinos KI; Spyrou N; Mantzoros CS; Dalamaga M
    Metabolism; 2019 Mar; 92():121-135. PubMed ID: 30445141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current biology of resistin.
    Steppan CM; Lazar MA
    J Intern Med; 2004 Apr; 255(4):439-47. PubMed ID: 15049878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
    Goralski KB; Sinal CJ
    Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.